Annual report pursuant to Section 13 and 15(d)

EQUITY (Narrative) (Details)

v3.10.0.1
EQUITY (Narrative) (Details)
$ / shares in Units, $ in Thousands, € in Millions
1 Months Ended 2 Months Ended 12 Months Ended
Mar. 07, 2017
USD ($)
Jul. 31, 2018
USD ($)
$ / shares
shares
Jan. 31, 2017
USD ($)
$ / shares
shares
Jan. 31, 2017
EUR (€)
shares
Feb. 08, 2019
USD ($)
Nov. 30, 2018
USD ($)
$ / shares
shares
Nov. 30, 2017
USD ($)
shares
Nov. 30, 2015
USD ($)
Nov. 30, 2015
EUR (€)
Class of Warrant or Right, Grants in Period, Net of Forfeitures | shares           4,488,854 1,144,647    
Class of Warrant or Right, Grants in Period, Exercise Price | $ / shares           $ 6.24      
Receipts on account of shares to be allotted           $ 2,253 $ 1,483    
Class of Warrant or Right, Exercises in Period | shares           136,646 0    
Proceeds from Warrant Exercises           $ 853      
Repayments of Convertible Debt $ 494         $ 177 $ 4,051    
Warrants subject to exercise price adjustments | shares           769,411 1,066,691    
Definitive agreements with an institutional investor [Member]                  
Units Issued During Period, Units | shares   702,307 2,564,115 2,564,115   1,813,687 721,160    
Common Stock Shares Subscriptions     $ 16,000            
Units Issued During Period, Exercise Price | $ / shares   $ 6.24 $ 6.24            
Proceeds from Issuance of Private Placement   $ 4,600       $ 11,500 $ 4,500    
Class of Warrant or Right, Grants in Period, Exercise Price | $ / shares     $ 6.24            
Shares which have not been issued | shares           550,481      
Receipts on account of shares to be allotted           $ 2,300      
Payments of fees for shares not issued           328 225    
Stock-based compensation expenses due to issuance of warrants and shares           $ 121 $ 253    
Definitive agreements with accredited and other qualified investors [Member]                  
Units Issued During Period, Units | shares           1,237,642      
Units Issued During Period, Exercise Price | $ / shares           $ 6.24      
Proceeds from Issuance of Private Placement           $ 7,700      
Payments of fees for shares not issued           349      
Stock-based compensation expenses due to issuance of warrants and shares           125      
MaSTherCell [Member]                  
Proceeds from Issuance of Private Placement         $ 250 $ 21,500      
Convertible Debt               $ 1,800 € 1.6
Repayments of Convertible Debt     $ 1,700 € 1.5          
Stock Redeemed or Called During Period, Shares | shares     263,148 263,148